MedTrace Logo

Effect of Probiotics After Neurosurgery

NCT07200518 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-11-28

No results posted yet for this study

Summary

The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery.

The main question it aims to answer is:

• Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery?

Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.

Conditions

  • Healing

Interventions

DIETARY_SUPPLEMENT

OMNi-BiOTiC® Hetox multistrain probiotic

OMNi-BiOTiC® Hetox multistrain probiotic

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University Medical Centre Maribor

    collaborator OTHER

  • University Maribor

    lead OTHER

Principal Investigators

  • TOMAŽ ŠMIGOC, dr. med. · University Medical Centre Maribor

  • Sabina Fijan, Ph.D. · University of Maribor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2026-12-31
Completion
2027-06-01

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07200518 on ClinicalTrials.gov